Thomas E. Timbie, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 97,675 shares at $22.66 ($2.2M) on 2022-11-18, disclosed to the SEC on 2022-11-22.
Open-market sale of $2.2M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.66 | 37,605 | $852K | 38.7% |
| 2 | $22.66 | 37,605 | $852K | 38.7% |
| 3 | $23.46 | 2,101 | $49K | 2.2% |
| 4 | $22.08 | 224 | $5K | 0.2% |
| 5 | $22.11 | 10,070 | $223K | 10.1% |
| 6 | $22.11 | 10,070 |
| $223K |
| 10.1% |
| Total | $22.56 avg | 97,675 | $2.2M | 100% |
| Filing → |
| TMCI | SELL | 2023-01-20 | $1.3M | — | Filing → |
| TMCI | SELL | 2022-12-16 | $1.2M | — | Filing → |
| TMCI | SELL | 2022-11-18 | $1.0M | — | Filing → |